Coincentral

Coincentral is a leading publication focused on cryptocurrency news and education. It provides investors with easy to understand guides and market analysis, serving as a trusted resource for navigating the digital asset space.

Coincentral's Articles

Cango Dumps 4,451 BTC for $305M to Cut Debt and Fund AI Pivot

TLDR Cango sells 4,451 BTC to repay debt and pivot toward AI compute strategy $305M Bitcoin sale helps Cango reset finances and expand AI plans Cango cuts leverage

2026/02/09

USDT Issuer Tether to Hire 150 Staff as Global Expansion Continues

TLDR Tether will hire 150 more employees, growing its workforce from 300 over the next 18 months. Block plans to cut up to 10% of its staff, its third major layoff

2026/02/09

Quantum Computing Threat to Bitcoin Is Real but Not Immediate; CoinShares

TLDR CoinShares says a practical quantum threat to Bitcoin is likely at least a decade away. About 8% of Bitcoin sits in older addresses, but less than 0.1% is

2026/02/09

How Perpetual Futures Actually Work (And Why They Don’t Expire)

Perpetual futures have become one of the most widely used derivatives in crypto markets, yet they are often misunderstood. On the surface, they look similar to

2026/02/09

Block to Lay Off Hundreds Amid Restructure as Tether Grows Workforce

TLDR Block may cut up to 10% of staff during annual performance reviews ending in late February. This will be Block’s third large layoff round, following cuts in

2026/02/09

ENS Labs Ends Namechain Project Citing Ethereum Scaling and Low Fees

TLDR ENS Labs canceled its Namechain L2 project and will launch ENSv2 on Ethereum’s mainnet. Ethereum’s registration gas fees have dropped by over 99% since 2025

2026/02/09

Tesla (TSLA) Stock Rallies as Oppenheimer Increases Stake by 17.5%

TLDR Tesla stock jumped 4.1% to $413.50 as the company ramps up hiring for Elon Musk’s plan to build 100 GW of U.S. solar manufacturing capacity by end of 2028

2026/02/09

Eli Lilly (LLY) Stock Bets Big on China Biotech With $8.5B Innovent Deal

TLDR Eli Lilly signed its seventh partnership with Innovent Biologics to jointly develop cancer and immune disease treatments Lilly gains exclusive worldwide development

2026/02/09

Novo Nordisk (NVO) Stock Jumps 8% After FDA Pressures Hims to Pull Weight-Loss Pill

TLDR Novo Nordisk stock jumped 8% after Hims & Hers pulled its $49 weight-loss pill following FDA and legal pressure FDA signaled a broader crackdown on compounded

2026/02/09

QuantumScape (QS) Stock: What to Expect From Earnings Wednesday

TLDR QuantumScape reports Q4 2025 earnings after market close Wednesday, February 11, with Wall Street expecting a loss of $0.17 per share versus $0.22 last year

2026/02/09